333 related articles for article (PubMed ID: 8832062)
1. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells.
Cavet ME; West M; Simmons NL
Br J Pharmacol; 1996 Jul; 118(6):1389-96. PubMed ID: 8832062
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.
Pauli-Magnus C; von Richter O; Burk O; Ziegler A; Mettang T; Eichelbaum M; Fromm MF
J Pharmacol Exp Ther; 2000 May; 293(2):376-82. PubMed ID: 10773005
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
Wu X; Whitfield LR; Stewart BH
Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes.
Farrell RJ; Menconi MJ; Keates AC; Kelly CP
Aliment Pharmacol Ther; 2002 May; 16(5):1021-31. PubMed ID: 11966513
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin.
Pauli-Magnus C; Mürdter T; Godel A; Mettang T; Eichelbaum M; Klotz U; Fromm MF
Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):337-43. PubMed ID: 11284449
[TBL] [Abstract][Full Text] [Related]
6. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein.
Ushigome F; Takanaga H; Matsuo H; Yanai S; Tsukimori K; Nakano H; Uchiumi T; Nakamura T; Kuwano M; Ohtani H; Sawada Y
Eur J Pharmacol; 2000 Nov; 408(1):1-10. PubMed ID: 11070177
[TBL] [Abstract][Full Text] [Related]
7. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein.
Karlsson J; Kuo SM; Ziemniak J; Artursson P
Br J Pharmacol; 1993 Nov; 110(3):1009-16. PubMed ID: 7905337
[TBL] [Abstract][Full Text] [Related]
8. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers.
Hunter J; Hirst BH; Simmons NL
Pharm Res; 1993 May; 10(5):743-9. PubMed ID: 8100632
[TBL] [Abstract][Full Text] [Related]
9. Characterization of MPP+ secretion across human intestinal Caco-2 cell monolayers: role of P-glycoprotein and a novel Na(+)-dependent organic cation transport mechanism.
Bleasby K; Chauhan S; Brown CD
Br J Pharmacol; 2000 Feb; 129(3):619-25. PubMed ID: 10711363
[TBL] [Abstract][Full Text] [Related]
10. Transepithelial vinblastine secretion mediated by P-glycoprotein is inhibited by forskolin derivatives.
Hunter J; Hirst BH; Simmons NL
Biochem Biophys Res Commun; 1991 Dec; 181(2):671-6. PubMed ID: 1684494
[TBL] [Abstract][Full Text] [Related]
11. Mediation of cimetidine secretion by P-glycoprotein and a novel H(+)-coupled mechanism in cultured renal epithelial monolayers of LLC-PK1 cells.
Dudley AJ; Brown CD
Br J Pharmacol; 1996 Mar; 117(6):1139-44. PubMed ID: 8882608
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of a substrate for P-glycoprotein to renal cysts in vitro.
Simmons NL; Hunter J; Jepson MA
Biochim Biophys Acta; 1995 Jul; 1237(1):31-6. PubMed ID: 7619839
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the transport of the organic cation [3H]MPP+ in human intestinal epithelial (Caco-2) cells.
Martel F; Calhau C; Azevedo I
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):505-13. PubMed ID: 10832604
[TBL] [Abstract][Full Text] [Related]
14. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
Dahan A; Sabit H; Amidon GL
AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
[TBL] [Abstract][Full Text] [Related]
15. Interaction of digoxin with antihypertensive drugs via MDR1.
Takara K; Kakumoto M; Tanigawara Y; Funakoshi J; Sakaeda T; Okumura K
Life Sci; 2002 Feb; 70(13):1491-500. PubMed ID: 11895100
[TBL] [Abstract][Full Text] [Related]
16. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia.
Horio M; Chin KV; Currier SJ; Goldenberg S; Williams C; Pastan I; Gottesman MM; Handler J
J Biol Chem; 1989 Sep; 264(25):14880-4. PubMed ID: 2570070
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators.
Hunter J; Jepson MA; Tsuruo T; Simmons NL; Hirst BH
J Biol Chem; 1993 Jul; 268(20):14991-7. PubMed ID: 8100817
[TBL] [Abstract][Full Text] [Related]
18. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia.
Stephens RH; O'Neill CA; Warhurst A; Carlson GL; Rowland M; Warhurst G
J Pharmacol Exp Ther; 2001 Feb; 296(2):584-91. PubMed ID: 11160647
[TBL] [Abstract][Full Text] [Related]
19. Interaction of pristinamycin IA with P-glycoprotein in human intestinal epithelial cells.
Phung-Ba V; Warnery A; Scherman D; Wils P
Eur J Pharmacol; 1995 Jan; 288(2):187-92. PubMed ID: 7720780
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on sodium transport and Na+,K+-ATPase activity in Caco-2 and rat jejunal epithelial cells: effects of dopamine.
Vieira-Coelho MA; Soares-da-Silva P
Life Sci; 2001 Sep; 69(17):1969-81. PubMed ID: 11589512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
